ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Fluidigm Corporation

Fluidigm Corporation (FLDM)

3,71
0,00
(0,00%)
Fermé 09 Février 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
3,71
Prix Achat
3,69
Prix Vente
4,03
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
Clôture Veille
3,71
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
79 395 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-3,95
Bénéfice par action (BPA)
-0,94
Chiffre d'affairess
106,34M
Bénéfice net
-74,66M

À propos de Fluidigm Corporation

Fluidigm Corp manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. These tools are based on microfluidics and mass cytometry technologies. It sells instruments and consumables, including integrated fluidic circuits, assays, and reagents. Sl... Fluidigm Corp manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. These tools are based on microfluidics and mass cytometry technologies. It sells instruments and consumables, including integrated fluidic circuits, assays, and reagents. Slightly more than half of the firm's revenue comes from the sale of Consumables. Fluidigm primarily sells its products to academic institutions, clinical laboratories, and biopharmaceutical companies. The majority of revenue is generated in the United States followed by EMEA and Asia-Pacific. Show more

Secteur
Lab Analytical Instruments
Industrie
Lab Analytical Instruments
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-

FLDM Dernières nouvelles

Fluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc.

New Trading Symbol (NASDAQ:LAB) Expected to be Effective April 6, 2022 Appoints New Management Team and Additional Board Members with Significant Experience to Reinvigorate Growth and Enhance...

Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion

SOUTH SAN FRANCISCO, Calif., April 01, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM) today announced that its stockholders have voted to approve all of the proposals related to the...

Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global

Caligan Partners to Vote “FOR” Casdin and Viking Transaction and All Other Fluidigm Proposals at the Special Meeting to be Reconvened on April 1, 2022 Fluidigm Board to Appoint Frank Witney, a...

Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution

Company Urges ALL Stockholders to Vote “FOR” the Proposals at the Special Meeting Parties to Terminate the Purchase Agreements if Stockholder Approval is Not Received on April 1 SOUTH SAN...

Fluidigm Adjourns Special Meeting of Stockholders Until April 1, 2022

SOUTH SAN FRANCISCO, Calif., March 25, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it convened and then adjourned, without conducting any other business, the...

Fluidigm Urges Stockholders to Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion TODAY

SOUTH SAN FRANCISCO, Calif., March 21, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today urged Fluidigm stockholders to vote “FOR” ALL proposals related to the previously...

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Fluidigm Stockholders Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion

SOUTH SAN FRANCISCO, Calif., March 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), today announced that leading independent proxy advisory firms Institutional Shareholder...

Fluidigm Announces Fourth Quarter and Full Year 2021 Financial Results 

SOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...

Fluidigm Announces Collaboration Agreement with the Abu Dhabi Stem Cells Center to Accelerate Imaging Mass Cytometry in Development of Targeted Stem Cell Therapies

SOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...

Fluidigm Files Preliminary Proxy Statement in Connection with Proposed Strategic Capital Infusion from Casdin Capital and Viking Global Investors

SOUTH SAN FRANCISCO, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM) today filed with the U.S. Securities and Exchange Commission (the “SEC”) a preliminary proxy...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

FLDM - Frequently Asked Questions (FAQ)

What is the current Fluidigm share price?
The current share price of Fluidigm is US$ 3,71
How many Fluidigm shares are in issue?
Fluidigm has 79 395 000 shares in issue
What is the market cap of Fluidigm?
The market capitalisation of Fluidigm is USD 294,56M
What is the 1 year trading range for Fluidigm share price?
Fluidigm has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Fluidigm?
The price to earnings ratio of Fluidigm is -3,95
What is the cash to sales ratio of Fluidigm?
The cash to sales ratio of Fluidigm is 2,77
What is the reporting currency for Fluidigm?
Fluidigm reports financial results in USD
What is the latest annual turnover for Fluidigm?
The latest annual turnover of Fluidigm is USD 106,34M
What is the latest annual profit for Fluidigm?
The latest annual profit of Fluidigm is USD -74,66M
What is the registered address of Fluidigm?
The registered address for Fluidigm is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Fluidigm website address?
The website address for Fluidigm is www.fluidigm.com
Which industry sector does Fluidigm operate in?
Fluidigm operates in the LAB ANALYTICAL INSTRUMENTS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MGOLMGO Global Inc
US$ 0,4191
(126,54%)
816,59M
CDTConduit Pharmaceuticals Inc
US$ 2,831
(82,65%)
144,17M
GSIWGarden Stage Ltd
US$ 0,79
(78,73%)
219,64M
TOIIWOncology Institute Inc
US$ 0,033
(58,88%)
7,27k
CYTHCyclo Therapeutics Inc
US$ 1,19
(54,55%)
84,73M
FTELFitell Corporation
US$ 2,70
(-57,01%)
2,3M
SGBXSafe and Green Holdings Corporation
US$ 0,6401
(-44,82%)
5,65M
NKLANikola Corporation
US$ 0,4432
(-41,10%)
52,44M
PLRXPliant Therapeutics Inc
US$ 7,785
(-34,85%)
6,44M
LIPOLipella Pharmaceuticals Inc
US$ 3,08
(-33,76%)
2,2M
MGOLMGO Global Inc
US$ 0,4191
(126,54%)
816,59M
RIMEAlgorhythm Holdings Inc
US$ 0,0169
(-20,66%)
274,2M
NVDANVIDIA Corporation
US$ 129,84
(0,90%)
228,2M
GSIWGarden Stage Ltd
US$ 0,79
(78,73%)
219,64M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0537
(14,74%)
212,29M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock